Difference between revisions of "Part:BBa K2287022"
Line 4: | Line 4: | ||
This is the coding sequence of recombinant human xanthine oxidase which is codon optimized for expression in E. coli. The product of this gene, xanthine oxidase, oxidises hypoxanthine to xanthine and xanthine to uric acid in human purine catabolism. With this enzyme, E. coli is able to transfer xanthine and hypoxanthine into uric acid.(fig.1) | This is the coding sequence of recombinant human xanthine oxidase which is codon optimized for expression in E. coli. The product of this gene, xanthine oxidase, oxidises hypoxanthine to xanthine and xanthine to uric acid in human purine catabolism. With this enzyme, E. coli is able to transfer xanthine and hypoxanthine into uric acid.(fig.1) | ||
+ | [[Image:feedback2.jpg|thumb|430px|left|'''Figure 1''': the process of generating uric acid in the pathway of de novo purine synthesis]] | ||
+ | [[Image:XOR structure.jpg|thumb|430px|right|'''Figure 2''': the structure of XOR PDB ID:2ckj]] | ||
+ | We first cultured E. coli with XOR gene in regular LB medium, but no activity of XOR was detected. | ||
+ | [[Image:XOR-blk.jpg|thumb|350px|center|'''Figure 3''': No uric acid was detected when bacteria was cultured in regular LB medium]] | ||
+ | Since uric acid is reported to cause cell death, we speculated that expression of XOR in large quantity was baneful and thus expression was suppressed. Therefore, we removed IPTG and counted on leakage expression of XOR. XOR activity was tested following the same procedure, but still no uric acid production was detected. | ||
+ | [[Image:XOR-noI.jpg|thumb|350px|center|'''Figure 4''': No uric acid was detected when IPTG was removed]] | ||
+ | When we learnt that XOR contains molybdopterin cofactors as active catalytic site, we added 1mM sodium molybdate into regular LB medium and cultured E. coli with XOR gene under same conditions as before. IPTG was added in experiment group while removed in control group. | ||
+ | [[Image:XOR-contrast.jpg|thumb|350px|center|'''Figure 5''': E. coli with XOR showed xanthine oxidation activity and uric acid production without IPTG in LB with sodium molybdate (1mM), but not with IPTG. In LB with sodium molybdate (1mM) and without IPTG, XOR could fold correctly and demonstrate catalytic activity.]] | ||
+ | Then we co-transformed the parts we designed before([https://parts.igem.org/Part:BBa_K2287021 prs],[https://parts.igem.org/Part:BBa_K2287023 purF],[https://parts.igem.org/Part:BBa_K2287024 purD],[https://parts.igem.org/Part:BBa_K2287025 purM],[https://parts.igem.org/Part:BBa_K2287026 purC],[https://parts.igem.org/Part:BBa_K2287027 purF K326Q]) with XOR to test uric acid production ability | ||
+ | [[Image:Withx.jpg|thumb|420px|left|'''Figure 6''': Comparison of uric acid production between E. coli with XOR gene over-expressing other enzymes and E. coli with XOR gene with extra xanthine]] | ||
+ | |||
+ | [[Image:Nox.jpg|thumb|420px|right|'''Figure 7''': Comparison of uric acid production between E. coli with XOR gene over-expressing other enzymes and E. coli with XOR gene without extra xanthine]] | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
− | |||
Latest revision as of 18:21, 1 November 2017
rhXOR
This is the coding sequence of recombinant human xanthine oxidase which is codon optimized for expression in E. coli. The product of this gene, xanthine oxidase, oxidises hypoxanthine to xanthine and xanthine to uric acid in human purine catabolism. With this enzyme, E. coli is able to transfer xanthine and hypoxanthine into uric acid.(fig.1)
We first cultured E. coli with XOR gene in regular LB medium, but no activity of XOR was detected.
Since uric acid is reported to cause cell death, we speculated that expression of XOR in large quantity was baneful and thus expression was suppressed. Therefore, we removed IPTG and counted on leakage expression of XOR. XOR activity was tested following the same procedure, but still no uric acid production was detected.
When we learnt that XOR contains molybdopterin cofactors as active catalytic site, we added 1mM sodium molybdate into regular LB medium and cultured E. coli with XOR gene under same conditions as before. IPTG was added in experiment group while removed in control group.
Then we co-transformed the parts we designed before(prs,purF,purD,purM,purC,purF K326Q) with XOR to test uric acid production ability
References
1.M. Ferreira Antunes, F.K. Eggimann, M. Kittelmann, et al. Human xanthine oxidase recombinant in E. coli: A whole cell catalyst for preparative drug metabolite synthesis Journal of Biotechnology., 235 (2016), pp. 3-10 Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 612
Illegal BamHI site found at 707
Illegal BamHI site found at 848
Illegal BamHI site found at 1617 - 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 957
Illegal NgoMIV site found at 2079
Illegal AgeI site found at 451
Illegal AgeI site found at 2458
Illegal AgeI site found at 2509
Illegal AgeI site found at 3505
Illegal AgeI site found at 3859 - 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 1438
Illegal SapI.rc site found at 1474
Illegal SapI.rc site found at 2071